Cryoglobulin types and rheumatoid factors associated with clinical manifestations in patients with hepatitis C virus infection

Digestive and Liver Disease

Volumn 39, Issue SUPPL. 1, 2007, Pages

  Agnello, Vincent ^a,b   Elfahal, Mutasim ^a,b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clinical manifestations; Cryoglobulins; HCV infection; Rheumatoid factors

Indexed keywords

CRYOGLOBULIN; HEPATITIS C ANTIGEN; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; RHEUMATOID FACTOR; T LYMPHOCYTE ANTIGEN; VERY LOW DENSITY LIPOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CELL TRANSFORMATION; CLINICAL FEATURE; CRYOGLOBULINEMIA; CRYOPRECIPITATION; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; IMMUNE RESPONSE; LIVER CIRRHOSIS; NONHODGKIN LYMPHOMA; NONHUMAN; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS;

CRYOGLOBULINS; HEPATITIS C, CHRONIC; HUMANS; RHEUMATOID FACTOR;

EID: 35348935594     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(07)80007-7     Document Type: Article

References (43)

1. Brouet J., Clauvel J., Danon F., Klein M., and Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57 (1974) 775-788
2. Meltzer M., and Franklin E. Cryoglobulinemia - a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 40 (1966) 828-836
3. Pawlotsky J., Roudot-Thoraval F., Simmonds P., Mellor J., Ben Yahia M., Andre C., et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 122 (1995) 169-173
4. Abruzzo J., and Christian C. The induction of a rheumatoid factor-like substance in rabbits. J Exp Med 114 (1961) 791-806
5. Franciotta D., Zardini E., Bono G., Brustia R., Minoli L., and Cosi V. Antigen-specific oligoclonal IgG in AIDS-related cytomegalovirus and toxoplasma encephalitis. Acta Neurol Scand 94 (1996) 215-218
6. El-Serag H., Hampel H., Yeh C., and Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36 (2002) 1439-1445
7. Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses surle Virus de l'Hepatite C. Medicine (Baltimore) 79 (2000) 47-56
8. Lunel F., Musset L., Cacoub P., Frangeul L., Cresta P., Perrin M., et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106 (1994) 1291-1300
9. Monti G., Galli M., Invernizzi F., Pioltelli P., Saccardo F., Monteverde A., et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM 88 (1995) 115-126
10. Musset L., Diemert M., Taibi F., Thi Huong Du L., Cacoub P., Leger J., et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 38 (1992) 798-802
11. Fornasieri A., and D'Amico G. Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis. Nephrol Dial Transplant ll Suppl 4 (1996) 25-30
12. Agnello V., and Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 40 (1997) 2007-2015
13. Kayali Z., Buckwold V., Zimmerman B., and Schmidt W. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 36 (2002) 978-985
14. Arase Y., Ikeda K., Murashima N., Chayama K., Tsubota A., Koida I., et al. Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med 37 (1998) 836-840
15. Agnello V. Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity. Ann Rheum Dis 57 (1998) 701-702
16. Knight G., Agnello V., Bonagura V., Barnes J., Panka D., and Zhang Q. Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId- positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds. J Exp Med 178 (1993) 1903-1911
17. Agnello V., Zhang Q., Abel G., and Knight G. The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clin Exp Rheumatol 13 Suppl 13 (1995) S101-S104
18. Casato M., Agnello V., Pucillo L., Knight G., Leoni M., Del Vecchio S., et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90 (1997) 3865-3873
19. Casali P., and Schettino E. Structure and function of natural antibodies. Curr Top Microbiol Immunol 210 (1996) 167-179
20. Mazzaro C., Franzin F., Tulissi P., Pussini E., Crovatto M., Carniello G., et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 77 (1996) 2604-2613
21. Casato M., Mecucci C., Agnello V., Fiorilli M., Knight G., Matteucci C., et al. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 99 (2002) 2259-2261
22. Agnello V., Chung R., and Kaplan L. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327 (1992) 1490-1495
23. Agnello V., Zang Q., EllCahal M., Abel G., and Knight G. Association of HCV with VLDL in type II cryoglobulinemia. 3rd International Meeting on Hepatitis C Virus and related viruses (1995), Gold Coast, Australia
24. Liu E., Knight G., and Agnello V. Hepatitis C virus but not GB virus C/ hepatitis G virus has a role in type II cryoglobulinemia. Arthritis Rheum 42 (1999) 1898-1901
25. Sung V., Shimodaira S., Doughty A., Picchio G., Can H., Yen T., et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77 (2003) 2134-2146
26. Agnello V., and De Rosa F. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 40 (2004) 341-352
27. Ray R., Lagging L., Meyer K., and Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70 (1996) 4438-4443
28. Machida K., Cheng K., Sung V., Shimodaira S., Lindsay K., Levine A., et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 101 (2004) 4262-4267
29. Zignego A., Giannelli F., Marrocchi M., Mazzocca A., Ferri C., Giannini C., et al. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 31 (2000) 474-479
30. Kitay-Cohen Y., Amiel A., Hilzenrat N., Buskila D., Ashur Y., Fejgin M., et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 96 (2000) 2910-2912
31. Zuckerman E., Zuckerman T., Sahar D., Streichman S., Attias D., Sabo E., et al. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 112 (2001) 364-369
32. Sansonno D., Tucci F., De Re V., Lauletta G., Montrone M., Libra M., et al. HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation. Hepatology 42 (2005) 1019-1027
33. De Re V., De Vita S., Marzotto A., Rupolo M., Gloghini A., Pivetta B., et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor- producing cells that occur mainly in type II cryoglobulinemia. Blood 96 (2000) 3578-3584
34. Chart C., Hadlock K., Foung S., and Levy S. V(H)l-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 97 (2001) 1023-1026
35. Knight G., and Agnello V. WA monoclonal rheumatoid factors and non- Hodgkin lymphoma. Blood 97 (2001) 3319-3321
36. Quinn E., Chan C., Hadlock K., Foung S., Flint M., and Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98 (2001) 3745-3749
37. Gorevic P., and Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 28 (1991) 79-94
38. Invernizzi F., Galli M., Serino G., Monti G., Meroni P., Granatieri C., et al. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol 70 (1983) 73-82
39. Spencer J., Perry M., and Dunn-Walters D. Human marginal-zone B cells. Immunol Today 19 (1998) 421-426
40. Monteverde A., Ballare M., and Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 19 (1997) 99-110
41. Sansonno D., De Vita S., Iacobelli A., Cornacchiulo V., Boiocchi M., and Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 160 (1998) 3594-3601
42. De Vita S., Zagonel V., Russo A., Rupolo M., Cannizzaro R., Chiara G., et al. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer 77 (1998) 2032-2035
43. Hermine O., Lefrere F., Bronowicld J., Mariette X., Jondeau R., Eclache-Saudreau V., et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347 (2002) 89-94